Exodus Point Capital Management, LP Syros Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$3.26 - $4.66 $100,000 - $142,945	-30,675 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.08 - $5.66 $125,154 - $173,620	30,675 New	30,675 $137,000
Q2 2021 Aug 16, 2021	SELL	$5.01 - $7.48 $54,012 - $80,641	-10,781 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$7.19 - $14.95 $65,500 - $136,194	-9,110 Reduced 45.8%	10,781 $81,000
Q4 2020 Feb 16, 2021	BUY	$6.66 - $14.66 $132,474 - $291,602	19,891 New	19,891 $216,000

Q1 2020 May 15, 2020	SELL	$4.46 - $9.2 $164,016 - $338,330	-36,775 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.52 - $10.1 $166,222 - $371,427	36,775 New	36,775 $254,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $114M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.